Loading…
Sectoral / Thematic · LIC Mutual Fund · AMFI code 152026LIC Mf Healthcare Fund
Disclosed for 5 months, May 2026 to Sep 2026.Published as: LIC MF HEALTHCARE FUND
Portfolio value
₹99.4 Cr
down ₹3.7 Cr vs Aug 2026
- Stocks held
- 25
- up 2 vs Aug 2026
- Top 10 weight
- 60.1%
- of the portfolio in its ten largest
- Cash & debt
- 2.5%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 4, trimmed 17
LIC Mf Healthcare Fund is an active equity fund in the Sectoral / Thematic category from LIC Mutual Fund. In September 2026 it disclosed 25 stocks worth ₹99.4 Cr, down ₹3.7 Cr from Aug 2026. Its largest positions were Sun Pharmaceutical Industries Limited (9.6%), Divi's Laboratories Limited (9.1%), Neuland Laboratories Limited (6.1%); the ten largest together made up 60.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 62.9% of its equity. Cash and debt stood at 2.5%. Compared with Aug 2026 the fund entered 2 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
34%
Holds more cash than 34% of peers
What these mean: concentration · cash
Holdings in September 2026
Download CSVEvery line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 9.59% | down 0.51 pts | ₹9.5 Cr | down ₹88 L | Trimmed |
| Divi's Laboratories Limited | 9.07% | down 0.22 pts | ₹9 Cr | down ₹57 L | Trimmed |
| Neuland Laboratories Limited | 6.14% | down 0.24 pts | ₹6.1 Cr | down ₹47 L | Trimmed |
| Torrent Pharmaceuticals Limited | 6.04% | down 0.41 pts | ₹6 Cr | down ₹65 L | Trimmed |
| Apollo Hospitals Enterprise Limited | 5.75% | down 0.48 pts | ₹5.7 Cr | down ₹71 L | Trimmed |
| Aurobindo Pharma Limited | 5.23% | up 0.05 pts | ₹5.2 Cr | down ₹14 L | Trimmed |
| Navin Fluorine International Limited | 4.98% | down 0.67 pts | ₹4.9 Cr | down ₹88 L | Trimmed |
| Zydus Lifesciences Limited | 4.97% | up 0.18 pts | ₹4.9 Cr | up ₹0 L | Held |
| Aster DM Healthcare Limited | 4.61% | down 0.21 pts | ₹4.6 Cr | down ₹39 L | Trimmed |
| Fortis Healthcare Limited | 3.77% | down 0.02 pts | ₹3.7 Cr | down ₹16 L | Trimmed |
| Metropolis Healthcare Limited | 3.35% | up 0.18 pts | ₹3.3 Cr | up ₹6 L | Added |
| Gland Pharma Limited | 3.20% | down 0.73 pts | ₹3.2 Cr | down ₹87 L | Trimmed |
| Mankind Pharma Limited | 3.11% | up 0.21 pts | ₹3.1 Cr | up ₹10 L | Added |
| Nephrocare Health Services Ltd | 3.05% | up 3.05 pts | ₹3 Cr | up ₹3 Cr | New |
| Max Healthcare Institute Limited | 2.99% | up 0.44 pts | ₹3 Cr | up ₹34 L | Added |
| Suven Pharmaceuticals Limited | 2.95% | up 0.03 pts | ₹2.9 Cr | down ₹8 L | Trimmed |
| Glenmark Pharmaceuticals Limited | 2.61% | down 0.28 pts | ₹2.6 Cr | down ₹38 L | Trimmed |
| Global Health Limited | 2.59% | down 0.60 pts | ₹2.6 Cr | down ₹72 L | Trimmed |
| Cash, TREPS & receivables | 2.47% | up 0.99 pts | ₹2.5 Cr | up ₹93 L | Added |
| Dr Agarwals Health Care Limited | 2.46% | down 0.08 pts | ₹2.4 Cr | down ₹17 L | Trimmed |
| Biocon Limited | 2.37% | down 0.17 pts | ₹2.4 Cr | down ₹26 L | Trimmed |
| IPCA Laboratories Limited | 2.33% | down 0.85 pts | ₹2.3 Cr | down ₹97 L | Trimmed |
| Onesource Specialty Pharma Limited | 2.30% | up 0.09 pts | ₹2.3 Cr | up ₹0 L | Held |
| Piramal Pharma Limited | 1.43% | up 1.43 pts | ₹1.4 Cr | up ₹1.4 Cr | New |
| Syngene International Limited | 1.38% | up 0.40 pts | ₹1.4 Cr | up ₹36 L | Added |
| Artemis Medicare Services Limited | 1.26% | down 1.62 pts | ₹1.3 Cr | down ₹1.7 Cr | Trimmed |
What changed, Aug 2026 to Sep 2026
New New positions (2)
- Nephrocare Health Services Ltd3.1% · ₹3 Cr
- Piramal Pharma Limited1.4% · ₹1.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- Syngene International Limitedup ₹36 L (+0.40% pts)
- Max Healthcare Institute Limitedup ₹34 L (+0.44% pts)
- Mankind Pharma Limitedup ₹10 L (+0.21% pts)
- Metropolis Healthcare Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2026, the weight rose most in Healthcare Services (+1.4 pts), and fell most in Pharmaceuticals & Biotechnology (−0.8 pts) and Chemicals & Petrochemicals (−0.6 pts).
- Healthcare Services30.6% → 32.0%+1.4 pts
- Pharmaceuticals & Biotechnology63.7% → 62.9%−0.8 pts
- Chemicals & Petrochemicals5.7% → 5.1%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.7% | 63.7% | 62.9% |
| Healthcare Services | 28.5% | 30.6% | 32.0% |
| Chemicals & Petrochemicals | 5.9% | 5.7% | 5.1% |
Allocation in Sep 2026change vs Aug 2026
- Pharmaceuticals & Biotechnology (14)62.9%▼ 0.8 pts
- Healthcare Services (10)32.0%▲ 1.4 pts
- Chemicals & Petrochemicals (1)5.1%▼ 0.6 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Sep 2026
2.5%
▲ 1.0 pts vs Aug 2026
- Cash alone
- 2.5%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 1.5% – 7.1%
- lowest to highest · record 7.1% in May 2026
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.